PKCι, PKCζ and Par6 are required for pancreatic cancer cell transformed growth; thus, we hypothesized that molecular inhibition of aPKC PB1-domain-mediated interactions will inhibit the transformed signaling of both PKCι and PKCζ. Here, PARD6A is linked to familial pancreatic carcinoma.